72 results
8-K
EX-10.2
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
of the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the members of the Board; provided, however … , that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members
424B5
URGN
UroGen Pharma Ltd.
18 Jun 24
Prospectus supplement for primary offering
5:05pm
. As a result, the holders of a majority of the voting power represented at a meeting of shareholders have the power to elect all of our directors.
Under … by a simple majority vote of holders of our ordinary shares, participating and voting at an annual general meeting of our shareholders. Each director
424B5
wmofc6zi
17 Jun 24
Prospectus supplement for primary offering
4:19pm
8-K
EX-99.1
k8s03mnxgal8oqq 6d
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
986sxxioz1vflxvw
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
EX-10.1
qs96hiz95f2o pfr
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
EX-4.1
zo41h qryybvj21ynmw
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am